OSAM
ORIC icon

O'Shaughnessy Asset Management’s Oric Pharmaceuticals ORIC Stock Holding History

O'Shaughnessy Asset Management’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,544
Closed -$27K – 2825
2021
Q2 		$27K Buy
+1,544
New +$33.8K ﹤0.01% 1756

Other funds holding ORIC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

O'Shaughnessy Asset Management's ORIC Position: Q3 2021 in Review

O'Shaughnessy Asset Management sold out of Oric Pharmaceuticals (ORIC) in Q3 2021, closing a stake of 1,544 shares — an estimated $27K sold.

O'Shaughnessy Asset Management first reported a position in ORIC in Q2 2021 and held it in 1 quarter. The position peaked at $27K in Q2 2021. 82 funds tracked by Wall St. Rank hold ORIC as of Q3 2021.

  • O'Shaughnessy Asset Management reported no remaining Oric Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 1,544 Oric Pharmaceuticals shares in Q3 2021, an estimated $27K.
  • O'Shaughnessy Asset Management first reported a position in Oric Pharmaceuticals in Q2 2021 and held it in 1 quarter.
  • O'Shaughnessy Asset Management's Oric Pharmaceuticals position peaked at $27K in Q2 2021.
  • 82 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.